PIGP
Basic information
Region (hg38): 21:37062846-37073170
Previous symbols: [ "DSCR5" ]
Links
Phenotypes
GenCC
Source:
- developmental and epileptic encephalopathy, 55 (Strong), mode of inheritance: AR
- developmental and epileptic encephalopathy, 55 (Moderate), mode of inheritance: AR
- genetic developmental and epileptic encephalopathy (Supportive), mode of inheritance: AD
- developmental and epileptic encephalopathy, 55 (Strong), mode of inheritance: AR
- multiple congenital anomalies-hypotonia-seizures syndrome (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Developmental and epileptic encephalopathy 55 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 28334793 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (129 variants)
- Inborn_genetic_diseases (25 variants)
- Developmental_and_epileptic_encephalopathy,_55 (5 variants)
- PIGP-related_disorder (5 variants)
- Developmental_and_epileptic_encephalopathy (2 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIGP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000153682.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 26 | 27 | ||||
| missense | 48 | 52 | ||||
| nonsense | 5 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 0 | 3 | 57 | 26 | 5 |
Highest pathogenic variant AF is 0.00007372813
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PIGP | protein_coding | protein_coding | ENST00000464265 | 4 | 14001 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00189 | 0.743 | 125697 | 0 | 51 | 125748 | 0.000203 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.558 | 92 | 78.1 | 1.18 | 0.00000349 | 1018 |
| Missense in Polyphen | 10 | 16.714 | 0.59829 | 241 | ||
| Synonymous | -1.03 | 38 | 30.7 | 1.24 | 0.00000150 | 298 |
| Loss of Function | 0.882 | 5 | 7.63 | 0.655 | 3.22e-7 | 98 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000233 | 0.000233 |
| Ashkenazi Jewish | 0.000198 | 0.000198 |
| East Asian | 0.000598 | 0.000598 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000142 | 0.000141 |
| Middle Eastern | 0.000598 | 0.000598 |
| South Asian | 0.000458 | 0.000457 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Part of the complex catalyzing the transfer of N- acetylglucosamine from UDP-N-acetylglucosamine to phosphatidylinositol, the first step of GPI biosynthesis. {ECO:0000269|PubMed:10944123, ECO:0000269|PubMed:28334793}.;
- Pathway
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human);Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- 0.941
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.38
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.447
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.671
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pigp
- Phenotype
Zebrafish Information Network
- Gene name
- pigp
- Affected structure
- caudal fin
- Phenotype tag
- abnormal
- Phenotype quality
- folded
Gene ontology
- Biological process
- GPI anchor biosynthetic process;preassembly of GPI anchor in ER membrane
- Cellular component
- glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex;endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- phosphatidylinositol N-acetylglucosaminyltransferase activity